Alexion receives orphan drug designation for Soliris in Europe
The European Commission has granted orphan drug designation to Alexion Pharmaceuticals' Soliris (eculizumab), a terminal complement inhibitor, to treat patients ...
The European Commission has granted orphan drug designation to Alexion Pharmaceuticals' Soliris (eculizumab), a terminal complement inhibitor, to treat patients ...
The European Commission has approved Vertex Pharmaceuticals' oral medicine Kalydeco (ivacaftor) for people with cystic fibrosis (CF). Kalydeco is for ...
Swedish drugmaker Meda has agreed to acquire Italy-based Rottapharm Madaus for around €2.3bn as part of its strategy to boost ...
Pfizer and Baxter have entered into a definitive agreement under which Pfizer will acquire Baxter's portfolio of marketed vaccines for ...
Spain-based Almirall and AstraZeneca have entered into an agreement, involving Almirall transfering the rights to its respiratory franchise to Astrazeneca ...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead ...
Basilea to launch Zevtera(r)/Mabelio(r) (ceftobiprole medocaril) in Europe through a commercial services provider. Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that ...
CTI BioPharma Corp. (CTI) announced today that it has received approval from the Israeli Ministry of Health (MOH) for PIXUVRI® ...
AIDS can be brought under control by 2030, according to a report by the United Nations Aids agency. It said ...
AbbVie has now laid on the table a bid of £53.20 a share to acquire UK-headquartered Shire, up from last ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.